2026· Lokman Hekim Health Sciences· 0 citations· 30 references
TL;DR
Findings demonstrate that BA exerts a significant neuroprotective effect against rotenone-induced cytotoxicity by enhancing cell survival and modulating apoptosis-related pathways, suggesting a promising candidate for mitigating PD-associated neuronal damage.
Abstract
Introduction: Parkinson’s disease (PD) is characterized by progressive dopaminergic neurodegeneration and pathological α-synuclein aggregation. Mitochondrial dysfunction and oxidative stress are central to PD pathogenesis, and mitochondrial complex I inhibitors such as rotenone are widely used to model PD-related neurotoxicity in vitro. Boric acid (BA), a boron-containing compound with reported antioxidant and neuroprotective properties, has not been fully explored in PD-related apoptotic mechanisms. Therefore, this study aimed to investigate the neuroprotective and anti-apoptotic effects of BA in a rotenone-induced in vitro PD model using SH-SY5Y human neuroblastoma cells. Methods: SH-SY5Y cells were exposed to 50 µM rotenone to induce PD-like neurotoxicity and co-treated with BA at concentrations ranging from 100 to 800 µM. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptosis-related molecular changes were evaluated by real-time quantitative polymerase chain reaction and Western blot analyses, focusing on key regulators of mitochondrial apoptosis, including BAX (B-cell lymphoma 2 [BCL-2]-associated X protein), BCL-2, and cleaved caspase-3. Results: Rotenone treatment significantly reduced cell viability compared to control cells. Co-treatment with 200 µM BA markedly restored cell viability (**p<0.01), indicating a strong neuroprotective effect. Molecular analyses demonstrated that BA treatment significantly decreased the BAX/BCL-2 ratio in rotenone-treated cells (p=0.0295), suggesting an attenuation of mitochondria-mediated apoptotic signaling. Discussion and Conclusion: These findings demonstrate that BA exerts a significant neuroprotective effect against rotenone-induced cytotoxicity by enhancing cell survival and modulating apoptosis-related pathways. BA may represent a promising candidate for mitigating PD-associated neuronal damage, warranting further mechanistic and in vivo investigations.
Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra, largely driven by oxidative stress-mediated apoptosis. Caspase-3 acts as the central executioner in this cell death pathway. While oleuropein, a phenolic compound from
Olea europaea
, is known for...
Tommy Rizky Hutagalung, Kiking Ritarwan, S. Ibrahim et al.· Surgical neurology internati...· 0 citations
MyR attenuated RTN-induced neurotoxicity and was associated with improved behavioral performance, reduced OS, and preservation of neuronal morphology, which support the protective potential of MYR against RTN-induced neurotoxicity exhibiting Parkinsonian-like features.
O. Ozhan, Zehranur Erikci, A. Yıldız et al.· Journal of Molecular Histolo...· 0 citations
Background/Introduction: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by
dopaminergic neuronal loss, oxidative stress and mitochondrial dysfunction. Current therapies mainly provide symptomatic
relief without preventing disease progression. Carnosic acid (CA), a natural phenolic di...
Vagdevi H. R., Senthilkumar Sivanesan, Anand Koppal et al.· International Journal of Dru...· 0 citations
Purpose: Rotenone induces Parkinson's disease-like neurotoxicity through mitochondrial impairment, oxidative stress, and apoptosis. We investigated the neuroprotective efficacy of boldine against rotenone-induced cytotoxicity in human SH-SY5Y neuroblastoma cells.Material and Methods: SH-SY5Y cells were pretreated with...
Ferit Anıl Kocabaş, M. Erdoğan, O. Yılmaz· Journal of Basic and Clinica...· 0 citations